Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Welliver

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|May 1, 1987
Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infectionI K Rosner, R C Welliver, P J Edelson, et al.
The Journal of Infectious Diseases|August 1, 1994
Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccineR C Welliver, D A Tristram, K Batt, et al.
Vaccine|May 1, 1994
Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancementD A Tristram, R C Welliver, D A Hogerman, et al.
The Journal of Pediatrics|December 1, 1982
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infectionR C Welliver, D T Wong, E Middleton, et al.
Journal of Clinical Microbiology|July 1, 1982
Rapid diagnosis of parainfluenza virus infection in childrenD T Wong, R C Welliver, K R Riddlesberger, et al.
The Journal of Infectious Diseases|July 27, 2001
Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitisR P Garofalo, J Patti, K A Hintz, et al.
The Journal of Pediatrics|May 1, 1980
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responsesR C Welliver, T N Kaul, T I Putnam, et al.
The New England Journal of Medicine|October 8, 1981
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infectionR C Welliver, D T Wong, M Sun, et al.
The Journal of Infectious Diseases|January 1, 1993
Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months oldD A Tristram, R C Welliver, C K Mohar, et al.
American Journal of Diseases of Children (1960)|November 1, 1981
Secretory antibody response to respiratory syncytial virus infectionT N Kaul, R C Welliver, D T Wong, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|May 1, 1987
Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infectionI K Rosner, R C Welliver, P J Edelson, et al.
The Journal of Infectious Diseases|August 1, 1994
Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccineR C Welliver, D A Tristram, K Batt, et al.
Vaccine|May 1, 1994
Second-year surveillance of recipients of a respiratory syncytial virus (RSV) F protein subunit vaccine, PFP-1: evaluation of antibody persistence and possible disease enhancementD A Tristram, R C Welliver, D A Hogerman, et al.
The Journal of Pediatrics|December 1, 1982
Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infectionR C Welliver, D T Wong, E Middleton, et al.
Journal of Clinical Microbiology|July 1, 1982
Rapid diagnosis of parainfluenza virus infection in childrenD T Wong, R C Welliver, K R Riddlesberger, et al.
The Journal of Infectious Diseases|July 27, 2001
Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitisR P Garofalo, J Patti, K A Hintz, et al.
The Journal of Pediatrics|May 1, 1980
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responsesR C Welliver, T N Kaul, T I Putnam, et al.
The New England Journal of Medicine|October 8, 1981
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infectionR C Welliver, D T Wong, M Sun, et al.
The Journal of Infectious Diseases|January 1, 1993
Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months oldD A Tristram, R C Welliver, C K Mohar, et al.
American Journal of Diseases of Children (1960)|November 1, 1981
Secretory antibody response to respiratory syncytial virus infectionT N Kaul, R C Welliver, D T Wong, et al.
Pageof 9